Trifluridine Tipiracil: An FDA-approved medicine
-
The FDA approved the combination medicine of Trifluridine and Tipiracil in 2015 to treat patients with metastatic colorectal cancer and metastatic gastric or gastroesophageal junction adenocarcinoma. This combination medicine is sold under the brand name Lonsurf, and it is available in tablets in 15 mg Trifluridine/6.14 mg Tipiracil and 20 mg Trifluridine/8.19 mg. Trifluridine, a nucleoside metabolic inhibitor and Tipiracil hydrochloride, a thymidine phosphorylase inhibitor.
Trifluridine Tipiracil price is reasonable, and one can find this medicine with licensed generic medicine suppliers. Dial 18008891064 for more details about this combination medicine. -
Hello, what can you say about fenbendazole in the fight against cancer?
-
A recently published scientific article suggests that fenbendazole (and similar drugs) could potentially reactivate the p53 genome. Functioning as a tumor suppressor, p53 is known as the Custodian of the Genome. However, its inhibitory capacity may be reduced in some types of cancer. Check out this drug that really helps in the fight against cancer.